|
|
|
Print this article 
SOT Members Can Officially Join the Ocular Toxicology Specialty Section
The Ocular Toxicology Specialty Section (OTSS) was approved by SOT Council in July 2008 and will be available for SOT members to officially join in conjunction with the payment of 2009 dues. This is the newest of the 22 Specialty Sections that provide a forum for networking with peers who share an interest in your area of toxicology. These disciplinary groups may propose sessions for the Annual Meeting, exchange information via newsletters, present awards, host meetings, and participate in other scientific activities. You must be a member of SOT to join a Specialty Section. The membership dues are $15 for each group, and students and postdoctoral fellows may join their first specialty section at no cost.
Toxicologic research and development related to the eye generally fall into two categories: testing of agents for ocular irritation and toxicity, and testing of therapeutics for disease treatment/management. Traditionally, ocular irritation and toxicity assessment has fallen under the purview of the Dermal Specialty Section while testing of therapeutics may have fallen under the purview of the Neurotoxicology, Drug Discovery, or Regulatory and Safety Evaluation Specialty Sections. While ocular irritation research remains important, the progression of drug development for ocular diseases, particularly macular degeneration, has resulted in an increase in testing of ocular therapies. The primary goal of this new Specialty Section is to bring together researchers in academia, government, industry, and the private sector to share and optimize research testing strategies. The input of the charter members will significantly impact determining the best focus of the OTSS. Learn more about SOT Specialty Sections.
|
